phospho p53 ser15 antibody (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
86
Structured Review
Cell Signaling Technology Inc
phospho p53 ser15 antibody
Phospho P53 Ser15 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+p53+ser15/bio_rxiv__64898__2026__04__02__716058-64-11-78
Average 86 stars, based on 1 article reviews
Phospho P53 Ser15 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+p53+ser15/bio_rxiv__64898__2026__04__02__716058-64-11-78
Average 86 stars, based on 1 article reviews
phospho p53 ser15 antibody - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Pyrolysis Gas Chromatography:Article Title: Modified hTERT treatment ameliorates pressure overload-induced heart failure. Article Snippet: .. The primary antibodies: histone H 2 AX (1:1000, Cell Signalling Technology, 7631S), γH 2 AX (1:1000, Cell Signalling Technology, 9718S), 53BP1(1:1000, Cell Signalling Technology, 4937S), p53 (1:1000, Cell Signalling Technology, 2524S), Article Title: Modified hTERT treatment ameliorates pressure overload-induced heart failure Article Snippet: .. The primary antibodies: histone H 2 AX (1:1000, Cell Signalling Technology, 7631S), γH 2 AX (1:1000, Cell Signalling Technology, 9718S), 53BP1(1:1000, Cell Signalling Technology, 4937S), p53 (1:1000, Cell Signalling Technology, 2524S), Transcranial Magnetic Stimulation:Article Title: CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions. Article Snippet: Equal amounts of protein (20–30 μg) were loaded on 10–12% SDS–polyacrylamide gels and transferred onto PVDF membranes (Bio-Rad, cat. no. 1620177). .. Membranes were blocked with 5% skim milk in TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween20) for 1 h at room temperature and subsequently incubated overnight at 4 °C with primary antibodies against CREB2/ATF4 (mouse monoclonal, clone B-3, 1:100; Santa Cruz Biotechnology, cat. no. sc-390063, RRID:AB_10917316), p53 (1:1000; Cell Signaling Technology (CST), cat. no. 12571, RRID:AB_27113937), Article Title: CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions Article Snippet: Equal amounts of protein (20–30 μg) were loaded on 10–12% SDS–polyacrylamide gels and transferred onto PVDF membranes (Bio-Rad, cat. no. 1620177). .. Membranes were blocked with 5% skim milk in TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20) for 1 h at room temperature and subsequently incubated overnight at 4 °C with primary antibodies against CREB2/ATF4 (mouse monoclonal, clone B-3, 1:100; Santa Cruz Biotechnology, cat. no. sc-390063, RRID: AB_10917316), p53 (1:1000; Cell Signaling Technology (CST), cat. no. 12571, RRID: AB_27113937), Incubation:Article Title: CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions. Article Snippet: Equal amounts of protein (20–30 μg) were loaded on 10–12% SDS–polyacrylamide gels and transferred onto PVDF membranes (Bio-Rad, cat. no. 1620177). .. Membranes were blocked with 5% skim milk in TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween20) for 1 h at room temperature and subsequently incubated overnight at 4 °C with primary antibodies against CREB2/ATF4 (mouse monoclonal, clone B-3, 1:100; Santa Cruz Biotechnology, cat. no. sc-390063, RRID:AB_10917316), p53 (1:1000; Cell Signaling Technology (CST), cat. no. 12571, RRID:AB_27113937), Article Title: CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions Article Snippet: Equal amounts of protein (20–30 μg) were loaded on 10–12% SDS–polyacrylamide gels and transferred onto PVDF membranes (Bio-Rad, cat. no. 1620177). .. Membranes were blocked with 5% skim milk in TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20) for 1 h at room temperature and subsequently incubated overnight at 4 °C with primary antibodies against CREB2/ATF4 (mouse monoclonal, clone B-3, 1:100; Santa Cruz Biotechnology, cat. no. sc-390063, RRID: AB_10917316), p53 (1:1000; Cell Signaling Technology (CST), cat. no. 12571, RRID: AB_27113937), Article Title: Enhancement of NK cell activity via DNA-sensing inhibition by Poxin transgene Article Snippet: Protein concentrations were determined with the BCA Protein Assay Kit (Thermo Fisher). .. Proteins were then transferred onto a PVDF membrane, blocked with PBST buffer containing 5 % skim milk for 1 h at room temperature, and incubated overnight at 4 °C with primary antibodies, including phospho-STING (Ser366) (#19781, Cell Signaling Technology (CST)), STING (#13647, CST), phospho-TBK1 (Ser172) (#5483, CST), TBK1 (#3504, CST), phospho-IRF3 (S386) (ab76493, Abcam), IRF3 (#4302, CST), Cell-Signaling:Article Title: CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions. Article Snippet: Equal amounts of protein (20–30 μg) were loaded on 10–12% SDS–polyacrylamide gels and transferred onto PVDF membranes (Bio-Rad, cat. no. 1620177). .. Membranes were blocked with 5% skim milk in TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween20) for 1 h at room temperature and subsequently incubated overnight at 4 °C with primary antibodies against CREB2/ATF4 (mouse monoclonal, clone B-3, 1:100; Santa Cruz Biotechnology, cat. no. sc-390063, RRID:AB_10917316), p53 (1:1000; Cell Signaling Technology (CST), cat. no. 12571, RRID:AB_27113937), Article Title: CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions Article Snippet: Equal amounts of protein (20–30 μg) were loaded on 10–12% SDS–polyacrylamide gels and transferred onto PVDF membranes (Bio-Rad, cat. no. 1620177). .. Membranes were blocked with 5% skim milk in TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20) for 1 h at room temperature and subsequently incubated overnight at 4 °C with primary antibodies against CREB2/ATF4 (mouse monoclonal, clone B-3, 1:100; Santa Cruz Biotechnology, cat. no. sc-390063, RRID: AB_10917316), p53 (1:1000; Cell Signaling Technology (CST), cat. no. 12571, RRID: AB_27113937), Membrane:Article Title: Enhancement of NK cell activity via DNA-sensing inhibition by Poxin transgene Article Snippet: Protein concentrations were determined with the BCA Protein Assay Kit (Thermo Fisher). .. Proteins were then transferred onto a PVDF membrane, blocked with PBST buffer containing 5 % skim milk for 1 h at room temperature, and incubated overnight at 4 °C with primary antibodies, including phospho-STING (Ser366) (#19781, Cell Signaling Technology (CST)), STING (#13647, CST), phospho-TBK1 (Ser172) (#5483, CST), TBK1 (#3504, CST), phospho-IRF3 (S386) (ab76493, Abcam), IRF3 (#4302, CST), Concentration Assay:Article Title: Targeting the Non-Homologous End-Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence Article Snippet: 1 Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands 2 Present address: Amsterdam UMC, Vrije Universiteit Amsterdam, Dept. of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, De Boelelaan 1108, 1081 HZ Amsterdam, the Netherlands 3 Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands 4 Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands 5 Department of Surgical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands 6 Department of Pathology, VU University Amsterdam, 1081 HV Amsterdam, the Netherlands HZ Amsterdam, the Netherlands 7 Lead contact * These authors contributed equally † These authors contributed equally Correspondence: w.v.houdt@nki.nl, d.peeper@nki.nl |
